Factors influencing postoperative length of hospital stay after breast cancer surgery

Factors influencing postoperative length of hospital stay after breast cancer surgery. The breast, June 2013, Vol. 22(3), p.289-294

Marla, S., et al.

http://www.thebreastonline.com/article/PIIS0960977612001609/abstract?rss=yes

As part of a feasibility study to restructure the breast cancer services in Glasgow, factors influencing ‘postoperative length of stay’ and bed utilisation in patients undergoing surgery for breast cancer were examined.

Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery

Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery. The breast, June 2013, Vol. 22(3), p.273-76

Van Onselen, C., et al.

http://www.thebreastonline.com/article/PIIS0960977612001531/abstract?rss=yes

The purpose of this study was to evaluate for differences in occurrence and severity ratings of sleep disturbance, fatigue, and decreased energy in women who reported breast pain prior to surgery for breast cancer. Of the 390 women who completed self-report measures for each symptom, 28.2% reported pain in their breast prior to surgery. 

International guidelines for management of metastatic breast cancer

International guidelines for management of metastatic breast cancer from the European School of Oncology - MBC Task Force: Surveillance, staging and evaluation of patients with early-stage and metastatic breast cancer. The breast, June 2013, Vol. 22(3), p.203-10

Lin, N.U, et al.

http://www.thebreastonline.com/article/S0960-9776(13)00062-3/abstract

In clinical practice, the surveillance and follow-up of patients with breast cancer (BC) is quite variable. At the 7th European Breast Cancer Conference, the ESO-MBC Task Force convened a series of lectures, followed by open debate, on the use of physical examination, imaging, and laboratory tests in patients with early-stage BC, and for restaging evaluations and follow-up among patients with MBC.

Leser-Trelat sign and breast cancer

Leser-Trelat sign and breast cancer. The lancet, May 2013, Vol. 381(9878), p.1653

Al Ghazal, P., et al.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61257-4/fulltext?rss=yes

A 71-year-old, obese woman presented to our clinic with multiple seborrheic keratoses over her entire body. She reported the rapid appearance of the tumours several weeks before an initial diagnosis of breast cancer. 

Persistent pain and sensory disturbances after treatment for breast cancer

Persistent pain and sensory disturbances after treatment for breast cancer: six-year nationwide follow-up study. BMJ 2013; 346.

Mejdahl, M.K., et al.

http://www.bmj.com/highwire/filestream/640586/field_highwire_article_pdf/0/bmj.f1865.full.pdf

Objective: Toexamine thedevelopment of persistent pain after treatment for breast cancer and to examine risk factors associated with continuing pain.Design: Repeated cross sectional study in a previously examined

nationwide cohort.All eligible women who underwent surgery for primary breast cancer in Denmark in 2005 and 2006 and were examined in 2008 were surveyed again with the same questionnaire.

Breast reconstruction modality outcome study

Breast reconstruction modality outcome study: A comparison of expander/implants and free flaps in select patients. Plastic and reconstructive surgery, May 2013, Vol. 131(5), p.928-34.

Fischer, J.P., et al.

http://journals.lww.com/plasreconsurg/Fulltext/2013/05000/Breast_Reconstruction_Modality_Outcome_Study___A.2.aspx

Choosing a breast reconstructive modality after mastectomy is a critical step involving complex decisions. The authors provide outcomes data comparing two common reconstructive modalities to assist patients and surgeons in preoperative counselling and discussions.

Repairing the high-riding nipple with reciprocal transposition flaps

Repairing the high-riding nipple with reciprocal transposition flaps. Plastic and reconstructive surgery, April 2013, Vol. 131(4), p.687-89.

Spear, S.L., et al.

http://journals.lww.com/plasreconsurg/Abstract/2013/04000/Repairing_the_High_Riding_Nipple_with_Reciprocal.5.aspx

The high-riding nipple-areola complex is a clinical problem that can be encountered following cosmetic and reconstructive breast surgery. Because of the desire to avoid scars on the superior aspect of the breast and the limited availability of superior breast skin, it can be technically challenging to place the nipple-areola complex in a lower position. 

Double venous system drainage in deep inferior epigastric perforator flap breast reconstruction

Double venous system drainage in deep inferior epigastric perforator flap breast reconstruction: a single-surgeon experience. Plastic and reconstructive surgery, April 2013, Vol. 131(4), p.671-76

Boutros, S.G.

http://journals.lww.com/plasreconsurg/Abstract/2013/04000/Double_Venous_System_Drainage_in_Deep_Inferior.1.aspx

Breast reconstruction with the deep inferior epigastric perforator (DIEP) flap has many advantages. The main drawback is the technical difficulty and risk of failure. Many flap failures are the result of venous insufficiency. The author explored the routine use of double venous system anastomosis in DIEP flap breast reconstruction.

Incidence of unilateral arm lymphoedema after breast cancer

Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.  The lancet oncology, May 2013, Vol. 14(6), p.500-15.

DiSippio, T., et al.

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(13)70076-7/abstract?rss=yes

The body of evidence related to breast-cancer-related lymphoedema incidence and risk factors has substantially grown and improved in quality over the past decade. We assessed the incidence of unilateral arm lymphoedema after breast cancer and explored the evidence available for lymphoedema risk factors.

Quality of life and symptoms in male breast cancer survivors

Quality of life and symptoms in male breast cancer survivors. The breast, Vol. 22(2), April 2013, p.197-9.

Ruddy, K.J., et al.

http://www.thebreastonline.com/article/PIIS0960977612002585/abstract?rss=yes

Little is known about quality of life and symptoms of male breast cancer survivors.

A new level 1 oncoplastic technique for breast conserving surgery

A new level 1 oncoplastic technique for breast conserving surgery: Rotation gladular flap. The breast, Vol. 22(2), April 2013, p.186-9.

Massey, E.J.D., et al.

http://www.thebreastonline.com/article/PIIS0960977613000143/abstract?rss=yes

When performing conservative surgery for breast cancer, breast reshaping can be a challenging procedure. Level 1 oncoplastic surgery (OPS) techniques, i.e. advancement or rotation of glandular flaps, should be performed when less than 20 per cent breast volume is excised.

Trends in tertiary breast reconstruction

Trends in tertiary breast reconstruction: Literature review and single centre experience. The breast, Vol. 22(2), April 2013, p.173-8.

Mohan, A.T., et al.

http://www.thebreastonline.com/article/PIIS0960977612001166/abstract?rss=yes

Autologous flap reconstruction can improve aesthetic results after failed implant reconstruction and be considered following previous failed autologous flap reconstruction. This study presents a review of the indications, motivation and outcomes of tertiary breast reconstruction.

An evaluation of patient reported outcomes following breast reconstruction utilizing Breast Q.

An evaluation of patient reported outcomes following breast reconstruction utilizing Breast Q.  The breast, Vol. 22(2), April, 2013, p.158-161.

Sugrue, R., et al.

http://www.thebreastonline.com/article/PIIS0960977612002457/abstract?rss=yes

Breast Q questionnaire measures patient's perceptions following breast reconstruction using quality of life and satisfaction. This study assessed patient reported outcomes following mastectomy and reconstruction utilizing Breast Q.

Aromatase inhibitors in the treatment of elderly women with metastatic breast cancer

Aromatase inhibitors in the treatment of elderly women with metastatic breast cancer. The breast, Vol. 22(2), April 2013, p.142-9.

Gluck, S., et al.

http://www.thebreastonline.com/article/PIIS0960977612002597/abstract?rss=yes

The proportion of elderly women in the population is rising, and in tandem, the incidence of breast cancer rises with age. Because of health and tolerability concerns, as well as life expectancy, physicians may be reluctant to advise a standard treatment regimen for elderly patients with metastatic breast cancer. 

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are not suitable for a "standard chemotherapy regimen"

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are not suitable for a "standard chemotherapy regimen": The CASA randomized trial.  The breast, Vol. 22(2), April 2013, p.130-7.

Crivellari, D., et al.

http://www.thebreastonline.com/article/PIIS0960977613000179/abstract?rss=yes

There is no optimal treatment for breast cancers lacking estrogen (ER) and progesterone (PgR) receptors in elderly women with co-morbidities that prevent use of “standard chemotherapy regimens” such as AC or CMF. The CASA trial studied pegylated liposomal doxorubicin and low dose, metronomic cyclophosphamide + methotrexate (CM) for older (>65), vulnerable women with operable, ER and PgR-negative breast cancer.

Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women

Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women. The breast, Vol. 22(2), April 2013, p.121-29.

Aydiner, A.

http://www.thebreastonline.com/article/PIIS0960977613000167/abstract?rss=yes

The present meta-analysis examines randomized trials of third-generation aromatase inhibitors (AIs) as alternatives to tamoxifen in three treatment settings: monotherapy, sequenced therapy and extended therapy. Eleven randomized controlled trials (RCTs) were chosen based on their similarity in terms of study design and included 34,070 post-menopausal women who had undergone surgery for estrogen-sensitive early breast cancer.

Gene expression profiling in breast cancer

Gene expression profiling in breast cancer: A clinical perspective. The breast, Vol. 22(2), April 2013, p.109-120.

Arpino, G., et al.

http://www.thebreastonline.com/article/PIIS0960977613000180/abstract?rss=yes

Gene expression profiling tests are used in an attempt to determine the right treatment for the right person with early-stage breast cancer that may have spread to nearby lymph nodes but not to distant parts of the body. These new diagnostic approaches are designed to spare people who do not need additional treatment (adjuvant therapy) the side effects of unnecessary treatment, and allow people who may benefit from adjuvant therapy to receive it.

Overview of the evidence on digital breast tomosynthesis in breast cancer detection

Overview of the evidence on digital breast tomosynthesis in breast cancer detection. The breast, Vol. 22(2), April 2013, p.101-08.

Houssami, N. and Skaane, P.

http://www.thebreastonline.com/article/S0960-9776(13)00019-2/abstract

Digital breast tomosynthesis (DBT, or 3D-mammography), a three-dimensional derivative of digital mammography, reduces the effect of tissue superimposition and may improve mammographic interpretation. In this review, we examined the evidence on the accuracy of DBT in clinical studies. Published studies of DBT were relatively small studies, mostly test-set observer (reader) studies or clinical series that included symptomatic and screen-recalled cases, and were generally enriched with cancers.

Breast screening controversy continues

Breast screening controversy continues. BMJ 2013; 346:f477.

Godlee, F. [editorial]

http://www.bmj.com/content/346/bmj.f477.pdf%2Bhtml


When the Marmot report on breast cancer screening was published in November last year, many will have hoped for an endtothisparticular controversy.Prompted by callsi n the BMJ for more honest information on the harms of screening (BMJ 2010;340:c3106, BMJ 2011;343:d6894), Marmot and his committee were charged with asking whether the screening programme should continue, and if so, what women should be
told about the risks of overdiagnosis.

Survival is better after lumpectomy than mastectomy in early breast cancer

Survival is better after lumpectomy than mastectomy in early breast cancer, US study shows. BMJ, 2013, 346:f557

Mayor, S.

http://www.bmj.com/content/346/bmj.f577.pdf%2Bhtml


Women with early stage breast cancer who are treated with lumpectomy and radiotherapy have significantly better survival than women who have a mastectomy, a retrospective study of US data has found.